Dr. Steven W. Corso, MD
Hematology & Oncology (Hematology & Oncology Physician)
101 E Wood St
Spartanburg, SC 29303
Who else practices at this address →
Spartanburg County is a federal mental health shortage area. About shortage areas
- Medicare participating
At a glance
- Medical school
- University of South Carolina School of Medicine (1988)
- Years since graduation
- 38
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 644
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1988Medical school: University of South Carolina School of Medicine
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
SC license 19093
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Spartanburg Medical Center Spartanburg, SC
- Pelham Medical Center Greer, SC
- Cherokee Medical Center Gaffney, SC
- Union Medical Center Union, SC
Medical groups
- Spartanburg Medical Center (1,078 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 644
- Services billed
- 13,140
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 528 | 270 |
| Established patient office or other outpatient visit, 40-54 minutes | 415 | 249 |
| Established patient office or other outpatient visit, 20-29 minutes | 335 | 261 |
| Insertion of needle into vein for collection of blood sample | 99 | 48 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 13 | 12 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 12 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 21 companies reported 85 payments worth $2,286 in total to this clinician.
| Novartis Pharmaceuticals Corporation | $751 |
|---|---|
| Gilead Sciences, Inc. | $248 |
| Pfizer Inc. | $240 |
| Daiichi Sankyo Inc. | $172 |
| E.r. Squibb & Sons, L.l.c. | $138 |
| Celgene Corporation | $98.68 |
| Janssen Biotech, Inc. | $92.48 |
| AbbVie Inc. | $78.16 |
| Food and Beverage | $1,620 |
|---|---|
| Long term medical supply or device loan | $667 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation Jan 23, 2025 | Long term medical supply or device loan KISQALI · Oncology · in-kind | $83.33 |
| Novartis Pharmaceuticals Corporation Feb 21, 2025 | Long term medical supply or device loan KISQALI · Oncology · in-kind | $83.33 |
| Novartis Pharmaceuticals Corporation Mar 26, 2025 | Long term medical supply or device loan KISQALI · Oncology · in-kind | $83.33 |
| Novartis Pharmaceuticals Corporation May 15, 2025 | Long term medical supply or device loan KISQALI · Oncology · in-kind | $83.33 |
| Novartis Pharmaceuticals Corporation Apr 24, 2025 | Long term medical supply or device loan KISQALI · Oncology · in-kind | $83.33 |
| Novartis Pharmaceuticals Corporation Jun 12, 2025 | Long term medical supply or device loan KISQALI · Oncology · in-kind | $83.33 |
| Novartis Pharmaceuticals Corporation Jul 25, 2025 | Long term medical supply or device loan KISQALI · Oncology · in-kind | $83.33 |
| Novartis Pharmaceuticals Corporation Aug 21, 2025 | Long term medical supply or device loan KISQALI · Oncology · in-kind | $83.33 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.